- Home
- DAY vs PCVX Comparison
DAY vs PCVX Comparison
Compare DAY & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAY
- PCVX
- Stock Information
- Founded
- DAY 1992
- PCVX 2013
- Country
- DAY United States
- PCVX United States
- Employees
- DAY N/A
- PCVX N/A
- Industry
- DAY
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- DAY
- PCVX Health Care
- Exchange
- DAY NYSE
- PCVX Nasdaq
- Market Cap
- DAY 9.5B
- PCVX 4.4B
- IPO Year
- DAY 2018
- PCVX 2020
- Fundamental
- Price
- DAY $55.29
- PCVX $32.94
- Analyst Decision
- DAY Buy
- PCVX Strong Buy
- Analyst Count
- DAY 13
- PCVX 10
- Target Price
- DAY $72.23
- PCVX $136.50
- AVG Volume (30 Days)
- DAY 1.8M
- PCVX 1.5M
- Earning Date
- DAY 07-30-2025
- PCVX 08-05-2025
- Dividend Yield
- DAY N/A
- PCVX N/A
- EPS Growth
- DAY N/A
- PCVX N/A
- EPS
- DAY 0.16
- PCVX N/A
- Revenue
- DAY $1,810,300,000.00
- PCVX N/A
- Revenue This Year
- DAY $11.02
- PCVX N/A
- Revenue Next Year
- DAY $11.46
- PCVX N/A
- P/E Ratio
- DAY $343.56
- PCVX N/A
- Revenue Growth
- DAY 14.97
- PCVX N/A
- 52 Week Low
- DAY $47.08
- PCVX $27.66
- 52 Week High
- DAY $82.69
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- DAY 40.40
- PCVX 46.08
- Support Level
- DAY $55.85
- PCVX $32.06
- Resistance Level
- DAY $58.22
- PCVX $33.81
- Average True Range (ATR)
- DAY 1.46
- PCVX 1.23
- MACD
- DAY -0.43
- PCVX -0.12
- Stochastic Oscillator
- DAY 9.31
- PCVX 19.86
About DAY DAYFORCE INC
Dayforce is a global technology company providing cloud-based human capital management solutions for large businesses looking to manage their payroll, tax, benefits, and talent intelligence. The company primarily services customers in the US with its flagship Dayforce platform but also services customers in select European countries as well as Australia and New Zealand. Dayforce services the Canadian HCM market with its Powerpay platform that specifically targets customers with less than 100 employees. As of fiscal 2024, the Dayforce platform accounted for almost 80% of companywide revenue and had 6,876 clients representing approximately 7.62 million employees.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.